Form 4: Anixa Biosciences Director Lewis H. Titterton Jr. Increases Stake in Company

Director Lewis H. Titterton Jr. reports purchasing additional shares of Anixa Biosciences, Inc. common stock.

Summary

• On June 10, 2024, Lewis H. Titterton Jr., a director of Anixa Biosciences, Inc., purchased 330 shares of common stock at a price of $2.6 per share.
• Following this transaction, Titterton directly owns 849,105 shares of Anixa Biosciences common stock.
• On June 11, 2024, Titterton purchased an additional 7,102 shares at $2.66 per share, increasing his direct ownership to 856,207 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be interpreted as a sign of confidence, but the amounts are relatively small and may not be highly significant.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for directors and officers to buy or sell shares of their company's stock, and these transactions are closely monitored by regulators and investors.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.

Key Dates